APO RESEARCH · REPORT
Clinical Trial
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
Product & engineering
Understand the product.
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
Selected research
Industry Research
Clinical Trial Industry Research Report 2026
Market perspective
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Scope
Read the full market overview
This report quantifies the global Clinical Trial market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Clinical Trial.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clinical Trial Market by Company
Fisher Clinical Services
Myoderm
Bilcare
CliniChain
Ancillare
MESM
ERG Holding
Apex Medical Research
Parexel
PRA Health
LabCorp (Covance)
Marken
AmerisourceBergen (World Courier)
Clinical Trial Segment by Type
Instruments(Products)
Consumables
Others
Clinical Trial Segment by Application
Procurement and Supplies
Rentals
Others
Clinical Trial Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Clinical Trial companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments(Products)
- Consumables
- Others
Applications
- Procurement and Supplies
- Rentals
- Others
Companies covered
- Fisher Clinical Services
- Myoderm
- Bilcare
- CliniChain
- Ancillare
- MESM
- ERG Holding
- Apex Medical Research
- Parexel
- PRA Health
- LabCorp (Covance)
- Marken
- AmerisourceBergen (World Courier)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clinical Trial by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Instruments(Products)
- 2.2.3 Consumables
- 2.2.4 Others
- 2.3 Clinical Trial by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Procurement and Supplies
- 2.3.3 Rentals
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Clinical Trial Breakdown Data by Type
- 3.1 Global Clinical Trial Historic Market Size by Type (2021-2026)
- 3.2 Global Clinical Trial Forecasted Market Size by Type (2027-2032)
4 Clinical Trial Breakdown Data by Application
- 4.1 Global Clinical Trial Historic Market Size by Application (2021-2026)
- 4.2 Global Clinical Trial Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Clinical Trial Market Perspective (2021-2032)
- 5.2 Global Clinical Trial Growth Trends by Region
- 5.2.1 Global Clinical Trial Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Clinical Trial Historic Market Size by Region (2021-2026)
- 5.2.3 Clinical Trial Forecasted Market Size by Region (2027-2032)
- 5.3 Clinical Trial Market Dynamics
- 5.3.1 Clinical Trial Industry Trends
- 5.3.2 Clinical Trial Market Drivers
- 5.3.3 Clinical Trial Market Challenges
- 5.3.4 Clinical Trial Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Clinical Trial Players by Revenue
- 6.1.1 Global Top Clinical Trial Players by Revenue (2021-2026)
- 6.1.2 Global Clinical Trial Revenue Market Share by Players (2021-2026)
- 6.2 Global Clinical Trial Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Clinical Trial Head Office and Area Served
- 6.4 Global Clinical Trial Players, Product Type & Application
- 6.5 Global Clinical Trial Manufacturers Established Date
- 6.6 Global Clinical Trial Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Clinical Trial Market Size (2021-2032)
- 7.2 North America Clinical Trial Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Clinical Trial Market Size by Country (2021-2026)
- 7.4 North America Clinical Trial Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Clinical Trial Market Size (2021-2032)
- 8.2 Europe Clinical Trial Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Clinical Trial Market Size by Country (2021-2026)
- 8.4 Europe Clinical Trial Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Trial Market Size (2021-2032)
- 9.2 Asia-Pacific Clinical Trial Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Clinical Trial Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Clinical Trial Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Clinical Trial Market Size (2021-2032)
- 10.2 South America Clinical Trial Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Clinical Trial Market Size by Country (2021-2026)
- 10.4 South America Clinical Trial Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Trial Market Size (2021-2032)
- 11.2 Middle East & Africa Clinical Trial Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Clinical Trial Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Clinical Trial Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Fisher Clinical Services
- 12.1.1 Fisher Clinical Services Company Information
- 12.1.2 Fisher Clinical Services Business Overview
- 12.1.3 Fisher Clinical Services Revenue in Clinical Trial Business (2021-2026)
- 12.1.4 Fisher Clinical Services Clinical Trial Product Portfolio
- 12.1.5 Fisher Clinical Services Recent Developments
- 12.2 Myoderm
- 12.2.1 Myoderm Company Information
- 12.2.2 Myoderm Business Overview
- 12.2.3 Myoderm Revenue in Clinical Trial Business (2021-2026)
- 12.2.4 Myoderm Clinical Trial Product Portfolio
- 12.2.5 Myoderm Recent Developments
- 12.3 Bilcare
- 12.3.1 Bilcare Company Information
- 12.3.2 Bilcare Business Overview
- 12.3.3 Bilcare Revenue in Clinical Trial Business (2021-2026)
- 12.3.4 Bilcare Clinical Trial Product Portfolio
- 12.3.5 Bilcare Recent Developments
- 12.4 CliniChain
- 12.4.1 CliniChain Company Information
- 12.4.2 CliniChain Business Overview
- 12.4.3 CliniChain Revenue in Clinical Trial Business (2021-2026)
- 12.4.4 CliniChain Clinical Trial Product Portfolio
- 12.4.5 CliniChain Recent Developments
- 12.5 Ancillare
- 12.5.1 Ancillare Company Information
- 12.5.2 Ancillare Business Overview
- 12.5.3 Ancillare Revenue in Clinical Trial Business (2021-2026)
- 12.5.4 Ancillare Clinical Trial Product Portfolio
- 12.5.5 Ancillare Recent Developments
- 12.6 MESM
- 12.6.1 MESM Company Information
- 12.6.2 MESM Business Overview
- 12.6.3 MESM Revenue in Clinical Trial Business (2021-2026)
- 12.6.4 MESM Clinical Trial Product Portfolio
- 12.6.5 MESM Recent Developments
- 12.7 ERG Holding
- 12.7.1 ERG Holding Company Information
- 12.7.2 ERG Holding Business Overview
- 12.7.3 ERG Holding Revenue in Clinical Trial Business (2021-2026)
- 12.7.4 ERG Holding Clinical Trial Product Portfolio
- 12.7.5 ERG Holding Recent Developments
- 12.8 Apex Medical Research
- 12.8.1 Apex Medical Research Company Information
- 12.8.2 Apex Medical Research Business Overview
- 12.8.3 Apex Medical Research Revenue in Clinical Trial Business (2021-2026)
- 12.8.4 Apex Medical Research Clinical Trial Product Portfolio
- 12.8.5 Apex Medical Research Recent Developments
- 12.9 Parexel
- 12.9.1 Parexel Company Information
- 12.9.2 Parexel Business Overview
- 12.9.3 Parexel Revenue in Clinical Trial Business (2021-2026)
- 12.9.4 Parexel Clinical Trial Product Portfolio
- 12.9.5 Parexel Recent Developments
- 12.10 PRA Health
- 12.10.1 PRA Health Company Information
- 12.10.2 PRA Health Business Overview
- 12.10.3 PRA Health Revenue in Clinical Trial Business (2021-2026)
- 12.10.4 PRA Health Clinical Trial Product Portfolio
- 12.10.5 PRA Health Recent Developments
- 12.11 LabCorp (Covance)
- 12.11.1 LabCorp (Covance) Company Information
- 12.11.2 LabCorp (Covance) Business Overview
- 12.11.3 LabCorp (Covance) Revenue in Clinical Trial Business (2021-2026)
- 12.11.4 LabCorp (Covance) Clinical Trial Product Portfolio
- 12.11.5 LabCorp (Covance) Recent Developments
- 12.12 Marken
- 12.12.1 Marken Company Information
- 12.12.2 Marken Business Overview
- 12.12.3 Marken Revenue in Clinical Trial Business (2021-2026)
- 12.12.4 Marken Clinical Trial Product Portfolio
- 12.12.5 Marken Recent Developments
- 12.13 AmerisourceBergen (World Courier)
- 12.13.1 AmerisourceBergen (World Courier) Company Information
- 12.13.2 AmerisourceBergen (World Courier) Business Overview
- 12.13.3 AmerisourceBergen (World Courier) Revenue in Clinical Trial Business (2021-2026)
- 12.13.4 AmerisourceBergen (World Courier) Clinical Trial Product Portfolio
- 12.13.5 AmerisourceBergen (World Courier) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst